According to Regeneron Pharmaceuticals's latest financial reports the company's total assets are $33.08 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $33.08 B | 13.23% |
2022-12-31 | $29.21 B | 14.86% |
2021-12-31 | $25.43 B | 48.19% |
2020-12-31 | $17.16 B | 15.93% |
2019-12-31 | $14.80 B | 26.17% |
2018-12-31 | $11.73 B | 33.89% |
2017-12-31 | $8.76 B | 25.68% |
2016-12-31 | $6.97 B | 24.32% |
2015-12-31 | $5.60 B | 46.16% |
2014-12-31 | $3.83 B | 30.05% |
2013-12-31 | $2.95 B | 41.84% |
2012-12-31 | $2.08 B | 57.19% |
2011-12-31 | $1.32 B | 21.49% |
2010-12-31 | $1.08 B | 46.98% |
2009-12-31 | $0.74 B | 2.34% |
2008-12-31 | $0.72 B | -22.65% |
2007-12-31 | $0.93 B | 60.02% |
2006-12-31 | $0.58 B | 38.16% |
2005-12-31 | $0.42 B | -10.49% |
2004-12-31 | $0.47 B | -1.34% |
2003-12-31 | $0.47 B | 22.47% |
2002-12-31 | $0.39 B | -20.96% |
2001-12-31 | $0.49 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $167.55 B | 406.52% | ๐บ๐ธ USA |
Novartis NVS | $99.94 B | 202.13% | ๐จ๐ญ Switzerland |
Amgen AMGN | $97.15 B | 193.69% | ๐บ๐ธ USA |
Sanofi SNY | $139.81 B | 322.66% | ๐ซ๐ท France |
Biogen BIIB | $26.84 B | -18.85% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $3.82 B | -88.42% | ๐บ๐ธ USA |